Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

STRATTERA Drug Profile

« Back to Dashboard
Strattera is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in STRATTERA is atomoxetine hydrochloride. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. There are seven tentative approvals for this compound. Additional details are available on the atomoxetine hydrochloride profile page.

Summary for Tradename: STRATTERA

Suppliers / Packagers: see list7
Bulk Api Vendors: see list71
Clinical Trials: see list12
Patent Applications: see list2,201
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:STRATTERA at DailyMed

Pharmacology for Tradename: STRATTERA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
atomoxetine hydrochloride
CAPSULE;ORAL021411-001Nov 26, 2002DISCNNoNo5,658,590*PED► subscribeY► subscribe
atomoxetine hydrochloride
CAPSULE;ORAL021411-007Feb 14, 2005RXYesNo5,658,590*PED► subscribeY► subscribe
atomoxetine hydrochloride
CAPSULE;ORAL021411-004Nov 26, 2002RXYesNo5,658,590*PED► subscribeY► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: STRATTERA

Drugname Dosage Strength RLD Submissiondate
atomoxetine hydrochlorideCapsules10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mgStrattera5/29/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.